-Function Oncology, a company transforming the operating system of precision medicine with CRISPR-powered platform technology, today announced an innovativ...
Game-changing continuous-batch production of RNA service removes process development and scale-up steps through automation and significantly cuts clinical ...
The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria Malaria is a serious and potentially fatal paras...
Cytiva shines as a model of sustainable principles in the dynamic field of life sciences, where pioneering innovation intersects with societal resp...
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315), a global biotechnology company focused on the development of novel antibody the...
Johnson & Johnson has announced the approval of OPSYNVI® by the U.S. Food and Drug Administration (FDA), marking a significant advanc...
Gilles Besin, Ph.D., CSO at Orbital: “Elegen's unique expertise in supplying...IVT-ready synthetic DNA constructs is very attractive ...
The innovative partnership seeks to revolutionize decentralized genomic testing, offering swift turnaround times to identify individuals wh...
Within3 and Array have announced a strategic partnership integrating synchronous and asynchronous insights management. This partnership is ...
Orchard Therapeutics, now under the stewardship of Kyowa Kirin, announces a historic milestone as the U.S. Food and Drug Administration (FDA) grants approv...
QIAGEN has announced a collaborative effort with the International Panel Physicians Association (IPPA) to bolster awareness of tuberculosis (TB) screening ...
AstraZeneca has announced its definitive agreement to acquire Fusion Pharmaceuticals Inc., a trailblazing clinical-stage biopharmaceutical company speciali...
The expanded facility will focus on manufacturing therapeutic antibody drugs, contributing to the delivery of breakthrough treatments to patients globally....
The completion of Cohort 3 marks a significant milestone, with six participants receiving therapy with 67Cu-SAR-bisPSMA at the highest sing...
© 2025 Biopharma Boardroom. All Rights Reserved.
